N/A
N=6
An Analysis of Dermabond vs. Non-Absorbable Sutures in Skin Closure for Brow Ptosis Procedures
Brow Ptosis · Surgical Wound
Bottom Line
View on ClinicalTrials.gov: NCT05981443 ↗Enrolled (actual)
6
Serious AEs
0.0%
Results posted
Apr 2025
Primary outcome: Primary: Scar Appearance — 7; 2.33 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Dermabond (Device); Non-Absorbable Sutures (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Cody Blanchard
- Primary completion
- Apr 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Scar Appearance |
2; 4 | — |
| PRIMARY Scar Appearance |
2; 4 | — |
| PRIMARY Number of Participants With Complications |
0; 0 | — |
Summary
The goal of this clinical trial is to compare Dermabond with non-absorbable sutures in skin closure after brow ptosis surgery. The main questions it aims to answer are:
* if Dermabond provides equivalent wound healing compared to conventional non-absorbable skin suture techniques
* if Dermabond provides equivalent scar appearance compared to conventional non-absorbable suture techniques
* if Dermabond results in equivalent complication rates compared to conventional non-absorbable suture techniques Participants will have be randomly selected to have either Dermabond or non-absorbable suture closure methods. Scar analysis and both participant and provider surveys will be performed to assess the differences between groups, if any.
Eligibility Criteria
Inclusion Criteria
- Patients undergoing bilateral direct excision brow lift for brow ptosis at the University of Kentucky Medical Center.
- Patients > 18 years of age.
- Patients must be able to follow up at the specified intervals.
- Patients who are able to give their own informed consent.
- Health Status: Variable health status reflective of general population of Kentucky. Patients will be healthy enough to be seen in an office setting.
- All patients will need to be proficient in the English language to understand the scale used for scar assessment
Exclusion Criteria
- Patients 100
- Allergy to Dermabond
- Adults with impaired consent capacity
- Incarcerated individuals
Data sourced from ClinicalTrials.gov (NCT05981443). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.